/stocks — the workspaceLOADING
All DMAARSEC filings, by type → · Earnings date & implied move · Search inside filings
Drugs Made In America Acquisition Corp. (DMAAR) is a blank checks company. Fundamentals from SEC filings; prices are end-of-day.
What’s behind DMAAR’s latest move — the size, how unusual the volume is, and the catalyst on the tape, explained and cited to the source.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
Not reported in XBRL for this filer.
Not reported in XBRL for this filer.
↓ Download the fiscal-year statement table (XLSX) · revenue, income, EPS, cash flow, balance sheet · from SEC XBRL, dated
A plain-English read on DMAAR plus an auto-SWOT — built from DMAAR's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate DMAAR using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
Has DMAAR been issuing shares? Offering history →
Projected from DMAAR's own SEC 8-K filing history — the year-over-year reporting pattern (about 47% land the exact day, about 91% within a week, measured across 4,713 past reports). No analyst estimates and nothing invented, and every confirmed date links to the source it came from, so you can check it yourself. It upgrades the momentDMAAR files or announces.
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
No lawmaker has disclosed a trade in DMAAR under the STOCK Act.
No tracked institution reported a position in DMAAR in the latest 13F round.
No open-market Form 4 buys or sells reported for DMAAR in the last ~6 months.